These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22592756)

  • 1. Percutaneous closure of patent foramen ovale: a near-perfect treatment ruined by careful study?
    Kent DM; Kitsios GD
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):414-5. PubMed ID: 22592756
    [No Abstract]   [Full Text] [Related]  

  • 2. Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders.
    Collado FMS; Poulin MF; Murphy JJ; Jneid H; Kavinsky CJ
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29910192
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of Transcatheter Closure of Patent Foramen Ovale.
    Neill J; Lin CH
    Methodist Debakey Cardiovasc J; 2017; 13(3):152-159. PubMed ID: 29744000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent foramen ovale closure for migraine prevention: the subject is still open.
    Dodick DW
    JACC Cardiovasc Interv; 2010 Mar; 3(3):288-9. PubMed ID: 20298986
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictors of recurrent stroke after percutaneous closure of patent foramen ovale.
    Rudolph V; Augustin J; Hofmann T; Hamm CW; Meinertz T; Köster R; Baldus S; Franzen O
    EuroIntervention; 2014; 9(12):1418-22. PubMed ID: 24169021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Closure of Patent Foramen Ovale in Preventing Subsequent Neurological Events: A Bayesian Network Meta-Analysis to Identify the Best Device.
    Varotto L; Bregolin G; Paccanaro M; De Boni A; Bonanno C; Perini F
    Cerebrovasc Dis; 2020; 49(2):124-134. PubMed ID: 32289794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Paradoxical Embolism (RoPE) Study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke.
    Kent DM; Thaler DE;
    Trials; 2011 Jul; 12():185. PubMed ID: 21794121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
    Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Marco Bonifati D; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Tomelleri G; Spalloni A; Giorli E; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Piras V; Rasura M; Simone AM; Gamba M; Cerrato P; Zedde ML; Micieli G; Melis M; Massucco D; Guido D; De Giuli V; Bonaiti S; D'Amore C; La Starza S; Iacoviello L; Padovani A;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical embolism through the patent foramen ovale--the elderly is where the money is.
    Meier B
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):971-2. PubMed ID: 19021283
    [No Abstract]   [Full Text] [Related]  

  • 11. Closure of patent foramen ovale: The abolition of stroke and asymptotic realities.
    Tan WA
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):517-8. PubMed ID: 15274164
    [No Abstract]   [Full Text] [Related]  

  • 12. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Trials.
    Mojadidi MK; Elgendy AY; Elgendy IY; Mahmoud AN; Elbadawi A; Eshtehardi P; Patel NK; Wayangankar S; Tobis JM; Meier B
    JACC Cardiovasc Interv; 2017 Nov; 10(21):2228-2230. PubMed ID: 29122137
    [No Abstract]   [Full Text] [Related]  

  • 14. Late complications of transcatheter closure of patent foramen ovale: new technology and new outcomes.
    Staubach S; Bertog S; Wunderlich N; Sievert H
    Future Cardiol; 2009 Sep; 5(5):503-10. PubMed ID: 19715414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention.
    Yuan K; Kasner SE
    Stroke Vasc Neurol; 2018 Jun; 3(2):84-91. PubMed ID: 30022802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New aspects of paradoxical embolism.
    Lehmeyer S; Lindhoff-Last E
    Vasa; 2011 Jan; 40(1):31-40. PubMed ID: 21283971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
    Carroll JD
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1070-1. PubMed ID: 19950331
    [No Abstract]   [Full Text] [Related]  

  • 18. SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists.
    Horlick E; Kavinsky CJ; Amin Z; Boudoulas KD; Carroll JD; Hijazi ZM; Leifer D; Lutsep HL; Rhodes JF; Tobis JM
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):859-874. PubMed ID: 30896894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
    Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design.
    Khattab AA; Windecker S; Jüni P; Hildick-Smith D; Dudek D; Andersen HR; Ibrahim R; Schuler G; Walton AS; Wahl A; Mattle HP; Meier B
    Trials; 2011 Feb; 12():56. PubMed ID: 21356042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.